AI revenue integrity for nephrology practices

Your payer changed the policy. Your team found out from the denial.

Payer medical policy changes, ESA biosimilar mandates, and drug-coverage redirects arrive without warning, and nephrology practices absorb the hit on claims already administered. Ember monitors every payer portal daily, surfaces changes before they cost you, and works every denial before the appeal window closes.

-57%denial rate reduction
Dailypayer policy monitoring
-45%cost to collect

Trusted by specialty groups and health systems

Ozark OrthopaedicsFinancial District Foot & Ankle CenterPeninsula Gastroenterology Medical GroupMVPQuantum RadiologyMoami Hand Center

Where nephrology revenue leaks

The revenue gaps Ember was built for

Nephrology practices face revenue pressure from two directions: strategic payer policy changes that arrive without warning, and billing-level coding errors that compound across recurring dialysis and infusion claims. Ember closes both.

01 · Payer policy changes

Drug coverage criteria and biosimilar mandates updated without notice.

Payers routinely issue new preferred drug lists, ESA biosimilar substitution requirements, and step-therapy criteria with hard effective dates. Practices that miss the change administer drugs that will be denied, often at high per-claim dollar amounts. Ember monitors every payer portal daily and surfaces policy changes with the revenue impact quantified against your claims volume and fee schedule.

Medical policy / LCD / formulary updatesCFO / Payer Relations

02 · Medical necessity & auth failures

Auth denials from plan-design nuances your team didn't know about.

Medicare Advantage coverage differs from commercial. A therapy covered under one plan design may not be covered under another. Auth obtained verbally gets denied in writing. Step-therapy documentation is complete but doesn't match the payer's current criteria. Ember flags these gaps before the drug is administered and builds the appeal package when denials occur.

Prior auth / step therapy / plan designPatient Access / RCM

03 · J-code specificity errors

Wrong J-code selection generating systematic underpayment across every drug claim.

ESA and iron biosimilar substitutions, new FDA approvals, and mid-year formulary changes create J-code mismatches that result in denials or underpayments across every claim until the error is caught. Manual billing teams find these through denial patterns, weeks or months late. Ember maintains a continuously updated J-code reference and validates every drug claim before submission.

J0885 · J0887 · Q5105 · J1756 · J3490Billing Team

04 · Dialysis MCP & drug-admin bundling

MCP tier downcoding and add-on sequencing errors on recurring claims.

ESRD monthly capitation drops to a lower-paying tier when face-to-face visits aren't counted correctly, and separately billable drug administration is mis-sequenced against initial, sequential, and concurrent infusion rules. Wastage modifier gaps add another layer of lost revenue. Ember validates every monthly dialysis and multi-drug session against payer rules before the claim submits.

90960 · 90962 · 96365 · JW · JZBilling Team

Three engines.
One source of truth.

Ember connects payer policy intelligence, clinical documentation, and contract terms into a single layer that covers nephrology revenue from the front end to adjudication. Daily policy monitoring feeds the coding engine. The coding engine feeds the appeal engine.

01 · Intelligence

Data Engine

Monitors payer portals daily across every state and contract. Ingests claims, fee schedules, and contract terms to model the financial impact of every policy change against your specific book of business.

Policy feedLive · daily

UHC MA

ESA biosimilar mandate · eff. 60d

$84k/yr

Aetna

Step therapy update · J0885

$31k/yr

BCBS

Iron coverage criteria revised

$12k/yr

Modeled against your fee schedule · multi-state contracts

02 · Audit

Coding Engine

Reviews 100% of nephrology encounters — dialysis MCP tiers, J-code selection, wastage modifiers, add-on sequencing, auth status — against national standards and payer-specific policies. Every flag carries a rule citation.

Audit#N-20471
90960ESRD MCP, 4+ visits
Pass
J0885Non-preferred ESA, use Q5105
Flag

Switch to biosimilar Q5105 — payer-preferred

UHC formulary · confidence 0.95

03 · Recovery

Appeal Engine

Reads CARC and RARC codes, retrieves dialysis and infusion records from the EHR, references the applicable payer policy and contract terms, drafts the appeal with all supporting attachments, and tracks every claim to adjudication.

Re: Claim #N-20471 · Denial CO-197

Step-therapy criteria are satisfied: prior ESA trial documented per LCD L33632 with auth on file, per contract §5.3

Denial received
Records retrieved
Appeal submitted · in review
Adjudication pending

Monitor upstream.
Recover downstream.

Policy intelligence prevents the strategic hits. Pre-bill audit prevents the coding errors. Automated appeals recover what slips through. All three run continuously, across every payer and every claim.

Payer policy intelligence

Find out about the policy change before it costs you.

Ember monitors every payer portal of interest daily, public sites, gated provider portals, and bulletins, and surfaces changes that affect your drugs, your codes, and your contracts, with the revenue impact quantified.

  • 1

    Daily portal scraping

    Pulls policy updates from public sites and authenticated payer portals across every state and payer of interest. Catches changes within 24 hours of publication.

  • 2

    Relevance analysis

    Filters every change against your drug formulary, dialysis and CPT codes, and payer contracts. Eliminates noise, only surfaces changes that affect your practice.

  • 3

    Revenue impact modeling

    Calculates the dollar impact of each policy change against your claims volume and fee schedule. Changes above your threshold trigger immediate escalation alerts.

  • 4

    Stakeholder routing

    Routes each alert to the right team, payer relations for contract escalation, patient access for patient outreach, RCM for coding-rule updates.

Alerts routed todaymulti-state
ESA biosimilar mandate · UHC MAPayer Relations
Step-therapy update · J0885RCM
Auth criteria revised · AetnaPatient Access

$127k/yr modeled impact across 3 changes

Quantified vs. your fee schedule · detected <24hr

24hr

Time to detection

Daily

Portal monitoring cadence

100%

Payer portals covered

Pre-bill audit + automated appeals

Catch it before the claim leaves. Work the denial before the window closes.

Ember audits every encounter before submission, J-code accuracy, MCP tiers, wastage modifiers, add-on sequencing, auth status, with the exact payer rule cited. When denials occur, the appeal lifecycle runs automatically: retrieval, drafting, packaging, and tracking.

Audit18
J0885

Use biosimilar Q5105

90960

MCP visit count

Flag9
CO-197

Auth not on file

Pull11
CO-50

Medical necessity

Push
PAID

Step-therapy appeal

-57%

Denial rate

100%

Encounters audited

-45%

Cost to collect

The full revenue cycle

From policy alert to adjudication. Covered.

Policy intelligence and pre-bill audit are the workhorses, but Ember protects nephrology revenue at every stage, from the first eligibility check to the last payer response.

Payer Policy Monitoring

Daily scraping of every payer portal, public and gated. Policy changes filtered to your formulary and contracts, with revenue impact quantified before your team has to go looking.

Prior Authorization

Checks auth requirements in real time for every dialysis and infusion drug, generates clinical documentation tied to the applicable medical-necessity criteria, and tracks every active auth to expiration.

AI Medical Coding

Reviews 100% of encounters, dialysis MCP tiers, J-codes, wastage modifiers, and administration codes, against national standards and payer-specific rules before claims submit.

Pre-bill Audit

Catches J-code errors, MCP tier downcoding, wastage documentation gaps, and auth mismatches before they generate denials. Every flag links to the exact payer rule that triggered it.

Denial Management

Full appeal lifecycle for every nephrology denial type, policy change, medical necessity, J-code error, auth failure, and bundling. Automated drafts tracked to adjudication.

Underpayment Recovery

Parses contracts to model what each dialysis and injectable drug claim should pay, then surfaces line-item underpayments on high-cost biologics and weight-based dosing at scale.

Recurring nephrology revenue, protected

-57%

denial rate

24hr

to policy-change detection

-45%

cost to collect

100%

encounters audited

Based on Ember AI benchmarks across customer practices. Results vary by payer mix and specialty.

Frequently asked questions

Everything you need to know about how Ember fits into your revenue cycle.

Yes. Ember AI connects seamlessly with all major EHRs and PMS platforms, including Epic, Oracle Cerner, athenahealth, and eClinicalWorks, as well as payer portals. Our standards-based integrations automate prior authorization, eligibility verification, and claims submission, allowing you to preserve existing infrastructure while modernizing the revenue cycle.
Ember AI deployments are measured in weeks, not months. Most organizations complete pilot launch in under 30 days and scale enterprise-wide within a quarter. We provide a structured onboarding playbook, technical support, and change-management guidance so your teams achieve measurable ROI rapidly with minimal IT lift.
Yes. Ember AI is fully HIPAA and SOC 2 Type II compliant and signs Business Associate Agreements (BAAs) with all covered entities. Protected Health Information (PHI) is encrypted in transit and at rest, supported by role-based access controls, detailed audit logging, and continuous monitoring. Your organization retains complete ownership and control of its data.
Health systems, MSOs, and health plans using Ember AI typically achieve:

- 50-75% reduction in FTE hours
- Faster cash acceleration
- Prevent 55%+ of denials

We provide ROI benchmarks and dashboards so you can track outcomes from day one.
Yes. Ember's coding and scrubbing logic is specialty-aware, it understands ESRD monthly capitation (MCP) dialysis tiers, home vs. in-center setting rules, ESA and injectable drugs, vascular access procedures, and CKD/AKI documentation, and validates claims against payer medical-necessity criteria before submission.
Ember counts face-to-face dialysis visits across the month and applies the correct age-banded MCP tier, so every ESRD patient is billed at the level the documentation supports instead of silently dropping to a lower-paying tier.
Yes. Ember selects the correct dialysis codes for home, in-center, and partial-month scenarios, handling transient, hospitalized, and start/stop per-diem logic, so monthly claims aren't denied or underpaid on setting.
Yes. Ember keeps J-codes, units, and documented wastage accurate on erythropoiesis-stimulating agents, iron, and vitamin D analogs, and confirms coverage, so injectable drug claims are paid in full instead of denied or taken back.
Ember connects to your existing EHR/PMS and payer systems with standards-based integrations, no rip-and-replace. Most teams pilot in days and see measurable ROI before scaling across service lines.

See what your payers changed last week

Bring us your top five payers and 30 days of denial data. We'll show you what Ember would have caught, and what it would have recovered.